{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:38:14Z","timestamp":1772757494146,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,11,6]],"date-time":"2002-11-06T00:00:00Z","timestamp":1036540800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Pulse therapy with high\u2010dose glucocorticoids was introduced 20\u00a0years ago as a treatment modality for autoimmune disease and transplant rejection. The most popular dermatological indication for pulse therapy is severe pemphigus. We reviewed the sequelae of 14 patients with pemphigus who were treated by pulse therapy. Seven of them reached complete remission, although three of them needed a new pulse course due to disease flare\u2010up. Adverse events were minor and confined to 60% of all patients: temporary facial flushing during pulse administration, sleep disturbances during the first night after pulse administration, and mood changes occurred during the week of pulse therapy. The study showed the possibility of oral instead of an intravenous route of dexamethasone pulse administration, which makes double\u2010blind placebo\u2010controlled trials ethically feasible. Fifty per cent of the patients reached complete remission. This retrospective study does not allow claims on the steroid\u2010sparing effect.<\/jats:p>","DOI":"10.1046\/j.1468-3083.2002.00413.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:42:59Z","timestamp":1047444179000},"page":"607-611","source":"Crossref","is-referenced-by-count":26,"title":["Dexamethasone pulse therapy in pemphigus"],"prefix":"10.1111","volume":"16","author":[{"given":"Gg","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jb","family":"Van De Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mf","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy for pemphigus","volume":"120","author":"Bystryn J","year":"1984","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890260105016"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80066-1"},{"key":"e_1_2_6_5_2","first-page":"633","article-title":"The big shot","author":"Editorial.","year":"1977","journal-title":"Lancet"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb04450.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb04767.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archderm.1996.03890360112026","article-title":"Curative treatment for pemphigus","volume":"132","author":"Pasricha J","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb07104.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb03549.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief high\u2010dose intravenous glucocorticoids","volume":"132","author":"Werth V","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03071.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0733-8635(18)30284-5","article-title":"Immunosuppressive agents in dermatology","volume":"11","author":"Ho V","year":"1993","journal-title":"Dermatol Clinics"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80193-0"},{"key":"e_1_2_6_15_2","first-page":"186","article-title":"The immunoaugmenting effects of cancer chemotherapeutic agents","volume":"13","author":"Mastralangelo M","year":"1986","journal-title":"Semin Oncol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199910000-00007"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70111-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1942.01500150014002"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.7.868"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90213-5"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1994.tb01811.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)80148-0"},{"key":"e_1_2_6_23_2","first-page":"2110","article-title":"Side effects of glucocorticoid treatment; experience of the optic neuritis treatment trial","volume":"269","author":"Chrousos G","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_24_2","first-page":"586","article-title":"Double blind trial of intravenous methylprednisolone in Guillain\u2013Barr\u00e9 syndrome","volume":"341","author":"Guillain\u2013Barr\u00e9 Syndrome Steroid Trial Group.","year":"1993","journal-title":"Lancet"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81508-3"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb04430.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-3083.2002.00413.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-3083.2002.00413.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T13:26:47Z","timestamp":1697549207000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-3083.2002.00413.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1046\/j.1468-3083.2002.00413.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-3083.2002.00413.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}